| 期 |
栏目 |
标题 |
文件 |
| 卷 32, 编号 7 (2021) |
Articles |
Osteoporosis in elderly patients: prevalence, pathogenesis, clinical presentations, prevention of complications |
|
| 卷 32, 编号 8 (2021) |
Articles |
Impact of aorto-coronary bypass surgery on quality of life and prognosis in patients with coronary heart disease |
|
| 卷 32, 编号 9 (2021) |
Articles |
OSTEOPOROSIS IN PATIENTS OF DIFFERENT AGE GROUPS: CLINICAL AND PATHOGENETIC ASPECTS AND TREATMENT WITH THE USE OF OSTEOMED, OSTEO-VIT D3 AND OSTEOMED FORTE DRUGS |
|
| 卷 32, 编号 10 (2021) |
Articles |
Comparison of the effectiveness of Osteomed, Osteomed Forte and Osteo-Vit D3 in the prevention of osteoporotic fractures of various localization |
|
| 卷 32, 编号 12 (2021) |
Articles |
The use of Osteomed, Osteomed Forte, and Osteo-Vit D3 in patients with osteoporosis: combination treatment for and prevention of fractures |
|
| 卷 32, 编号 11 (2021) |
Articles |
Analysis of the efficacy of Osteomed and Osteomed Forte in the treatment of osteoporotic fractures of various localization |
|
| 卷 33, 编号 1 (2022) |
Articles |
Osteoporosis in postmenopausal women: sociomedical significance, prevention of fractures with Osteomed and Osteomed Forte |
|
| 卷 33, 编号 2 (2022) |
Articles |
New coronavirus infection: clinical and pathogenetic aspects, prevention, importance of vitamins and trace elements |
|
| 卷 33, 编号 4 (2022) |
Articles |
Novel coronavirus infection: selenium, selenium-containing drugs, prevention of complications |
|
| 卷 33, 编号 3 (2022) |
Articles |
BIOCHAGA IS A SUBLIMATED BIRCH FUNGUS CHAGA EXTRACT WITH PROVEN ANTITUMOR AND IMMUNOMODULATORY EFFECTS, WHICH IS PRODUCED ACCORDING TO THE AUTHOR’S UNIQUE TECHNOLOGY |
|
| 卷 33, 编号 5 (2022) |
From Practice |
Novel coronavirus infection (COVID-19): epidemiology, clinical characteristics of patients, risk of complications, prevention, use of selenium-containing drugs |
|
| 卷 33, 编号 6 (2022) |
From Practice |
Comprehensive prevention of age-related and cardiovascular diseases: the use of the Russian natural remedy BioDihydroquercetin of the Baikal Legend trade mark |
|
| 卷 33, 编号 8 (2022) |
From Practice |
Chaga birch mushroom: anti-inflammatory, antioxidant, immunomodulatory, antiviral effects, the possibility of using the Russian drug BioChaga in patients with novel coronavirus infection (COVID-19) |
|
| 卷 33, 编号 9 (2022) |
Pharmacology |
The drug Cardioton: composition, pharmacological properties, the possibilities of preventing cardiovascular diseases |
|
| 卷 33, 编号 10 (2022) |
Articles |
DIHYDROQUERCETIN: PHARMACOLOGICAL PROPERTIES, POSSIBILITY OF USING THE DRUG IN CLINICAL PRACTICE |
|
| 卷 24, 编号 3 (2013) |
Articles |
A COMBINATION OF AMLODIPINE AND ATORVASTATIN IN CARDIOVASCULAR RISK REDUCTION |
|
| 卷 24, 编号 8 (2013) |
Articles |
MEDICINES WITH POTASSIUM AND MAGNESIUM IN COMPLEX PREVENTION OF COMPLICATIONS WITH PATIENTS WITH AH AND IHD |
|
| 卷 24, 编号 7 (2013) |
Articles |
QUALITY OF LIFE AND PROGNOSIS IN PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE WITH ATRIAL FIBRILLATION |
|
| 卷 24, 编号 12 (2013) |
Articles |
THE DRUG PREDUCTAL IN TREATMENT AND PREVENTIVE MEASURES FOR PATIENTS WITH ISCHEMIC HEART DISEASE |
|
| 卷 26, 编号 11 (2015) |
Articles |
MYOCARDIAL ELECTRICAL REMODELLING AND PROGNOSIS IN PATIENTS WITH ATRIAL FIBRILLATION |
|
| 卷 27, 编号 3 (2016) |
Articles |
Paroksizmal'naya fibrillyatsiya predserdiy: sutochnaya variabel'nost' serdechnogo ritma u muzhchin i zhenshchin |
|
| 卷 27, 编号 1 (2016) |
Articles |
ANALYSIS OF RISK FOR ATRIAL FIBRILLATION ACCORDING TO THE DATA OF DAILY HEART RHYTHM VARIABILITY |
|
| 卷 33, 编号 11 (2022) |
From Practice |
Selenium, selenium-containing drugs, antioxidant action: possibility of application in clinical practice |
|
| 卷 33, 编号 12 (2022) |
From Practice |
Application of hawthorn blood-red and rosehip fruits in the drug Kardioton in the prevention of various diseases |
|
| 卷 34, 编号 3 (2023) |
From Practice |
Prevention of calcium and vitamin D deficiency in osteoporosis: possibility of using combined drugs Osteomed, Osteomed Forte, Osteo-Vit D3 |
|
| 卷 34, 编号 1 (2023) |
Pharmacology |
The use of Osteomed, Osteomed Forte, and Osteo-Vit D3 in the prevention and therapy of fractures in patients with osteoporosis |
|
| 卷 34, 编号 2 (2023) |
From Practice |
The use of selenium-containing drugs in the prevention and treatment of complications in patients with COVID-19 |
|
| 卷 34, 编号 5 (2023) |
Pharmacology |
Cardiotone: pharmacological properties of hawthorn blood-red, possibility of use in patients with cardiovascular diseases |
|
| 卷 34, 编号 6 (2023) |
Pharmacology |
Flavonoids quercetin, dihydroquercetin (taxifolin): antioxidant and anti-ischemic effects, possibility of application in cardiology |
|
| 卷 34, 编号 7 (2023) |
From Practice |
Erectile dysfunction in men with cardiovascular disease: the possibility of prevention with Eromax |
|
| 卷 34, 编号 8 (2023) |
From Practice |
Possibility of using Femoklim in menopause women with cardiovascular pathologies |
|
| 卷 34, 编号 11 (2023) |
From Practice |
Anemia: epidemiology, clinical-pathogenetic associations, risk of development, selenium deficiency, prevention, selenium-containing drugs |
|
